India's Dr. Reddy's gets FDA nod for omeprazole
Indian drug maker Dr. Reddy's Laboratories Ltd (REDY.BO: Quote, Profile, Research)(RDY.N: Quote, Profile, Research) has received approval from the U.S. Food and Drug Administration for Omeprazole delayed-release capsules in 10 and 20 mg dosages, the regulator's Web site showed.
The drug, a generic equivalent
of Prilosec, is indicated in the treatment of stomach
ulcers and acid reflux.
November 01, 2007